These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19690679)

  • 21. A bis(amine-carboxylate) copper(II) coordination compound forms a two-dimensional metal-organic framework when crystallized from water and methanol.
    Munro OQ; Akerman MP; Gillham K
    Acta Crystallogr C; 2009 Sep; 65(Pt 9):m343-6. PubMed ID: 19726848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. {4-[(Carbamimidoylhydrazono)methyl-kappa2N1,N4]-5-hydroxymethyl-2-methylpyridinium-3-olate-kappaO}(methanol-kappaO)copper(II) dinitrate.
    Leovac VM; Vojinović-Jesić LS; Cesljević VI; Novaković SB; Bogdanović GA
    Acta Crystallogr C; 2009 Sep; 65(Pt 9):m337-9. PubMed ID: 19726846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoride protects boronic acids in the copper(I)-mediated click reaction.
    Jin S; Choudhary G; Cheng Y; Dai C; Li M; Wang B
    Chem Commun (Camb); 2009 Sep; (35):5251-3. PubMed ID: 19707636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity and characterization of heavy metal-resistant-endophytic bacteria from two copper-tolerant plant species on copper mine wasteland.
    Sun LN; Zhang YF; He LY; Chen ZJ; Wang QY; Qian M; Sheng XF
    Bioresour Technol; 2010 Jan; 101(2):501-9. PubMed ID: 19762232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel 3D Cd(II) metal-organic framework with an unprecedented (5,6)-connected topology based on isophthalate and 2-(3-pyridyl)imidazo[4,5-f]1,10-phenanthroline.
    Wang X; Liu G; Zhang J; Chen Y; Lin H; Zheng W
    Dalton Trans; 2009 Sep; (36):7347-9. PubMed ID: 19727451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solvent induced reactivity of 3,5-dimethylpyrazole towards zinc (II) carboxylates.
    Sarma R; Kalita D; Baruah JB
    Dalton Trans; 2009 Sep; (36):7428-36. PubMed ID: 19727464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper Phosphinate Complexes as Molecular Precursors for Ethanol Dehydrogenation Catalysts.
    Pokorny T; Doroshenko I; Machac P; Simonikova L; Bittova M; Moravec Z; Karaskova K; Skoda D; Pinkas J; Styskalik A
    Inorg Chem; 2023 Dec; 62(49):19871-19886. PubMed ID: 38032353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrel- and crown-shaped dodecanuclear copper(II) cages built from phosphonate, pyrazole, and hydroxide ligands.
    Chandrasekhar V; Nagarajan L; Clérac R; Ghosh S; Senapati T; Verma S
    Inorg Chem; 2008 Jun; 47(12):5347-54. PubMed ID: 18484717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A distorted cubic tetranuclear copper(II) phosphonate cage with a double-four-ring-type core.
    Chandrasekhar V; Nagarajan L; Clérac R; Ghosh S; Verma S
    Inorg Chem; 2008 Feb; 47(3):1067-73. PubMed ID: 18183972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New structural forms in molecular metal phosphonates: novel tri- and hexanuclear zinc(II) cages containing phosphonate and pyrazole ligands.
    Chandrasekhar V; Kingsley S; Rhatigan B; Lam MK; Rheingold AL
    Inorg Chem; 2002 Mar; 41(5):1030-2. PubMed ID: 11874331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncommon isonicotinamide supramolecular synthons in copper(II) complexes directed by nitrate and perchlorate anions.
    Daković M; Popović Z
    Acta Crystallogr C; 2009 Sep; 65(Pt 9):m361-6. PubMed ID: 19726853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First hexanuclear copper(II) pyrophosphate through hydrolysis of phosphodiester with a dicopper complex.
    Sabiah S; Varghese B; Murthy NN
    Chem Commun (Camb); 2009 Oct; (37):5636-8. PubMed ID: 19753382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A hexadecameric copper(II) phosphonate.
    Chandrasekhar V; Nagarajan L
    Dalton Trans; 2009 Sep; (34):6712-4. PubMed ID: 19690679
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.